Publication:
Giant cell arteritis: is the clinical spectrum of the disease changing?

Loading...
Thumbnail Image

Date

2019-07-29

Authors

González-Gay, Miguel Á.
Ortego-Jurado, Miguel
Ercole, Liliana
Ortego-Centeno, Norberto

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

BioMed Central Ltd.
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Background: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. Discussion: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. Conclusions: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications.

Description

MeSH Terms

Medical Subject Headings::Persons::Persons::Age Groups::Adult::Aged
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Biopsy
Medical Subject Headings::Check Tags::Female
Medical Subject Headings::Diseases::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Vasculitis, Central Nervous System::Giant Cell Arteritis
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Surgical Procedures, Minimally Invasive::Magnetic Resonance Imaging, Interventional
Medical Subject Headings::Check Tags::Male
Medical Subject Headings::Persons::Persons::Age Groups::Adult::Middle Aged
Medical Subject Headings::Diseases::Musculoskeletal Diseases::Rheumatic Diseases::Polymyalgia Rheumatica
Positron Emission Tomography Computed Tomography
Medical Subject Headings::Anatomy::Cardiovascular System::Blood Vessels::Arteries::Cerebral Arteries::Temporal Arteries
Medical Subject Headings::Chemicals and Drugs::Carbohydrates::Deoxy Sugars::Deoxyglucose::Fluorodeoxyglucose F18

DeCS Terms

CIE Terms

Keywords

Giant-cell arteritis, Polymyalgia rheumatic, FDG-PET/CT, Arteritis de células gigantes, Polimialgia reumática, Fluorodeoxyglucose F18, Fluorodesoxiglucosa F18, Positron Emission Tomography Computed Tomography, Tomografía Computarizada por Tomografía de Emisión de Positrones

Citation

González-Gay MÁ, Ortego-Jurado M, Ercole L, Ortego-Centeno N. Giant cell arteritis: is the clinical spectrum of the disease changing? BMC Geriatr. 2019 Jul 29;19(1):200.